• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤立性高 2 小时血浆葡萄糖风险评估列线图的开发和验证。

Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose.

机构信息

Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Endocrinology, The First Hospital of Jilin University, Changchun, China.

出版信息

Front Endocrinol (Lausanne). 2022 Sep 8;13:943750. doi: 10.3389/fendo.2022.943750. eCollection 2022.

DOI:10.3389/fendo.2022.943750
PMID:36157464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9492843/
Abstract

A tool was constructed to assess need of an oral glucose tolerance test (OGTT) in patients whose fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are normal. Data was collected from the longitudinal REACTION study conducted from June to November 2011 (14,686 subjects, aged ≥ 40 y). In people without a prior history of diabetes, isolated high 2-hour plasma glucose was defined as 2-hour plasma glucose ≥ 11.1 mmol/L, FPG < 7.0 mmol/L, and HbA1c < 6.5%. A predictive nomogram for high 2-hour plasma glucose was developed stepwise logistic regression. Discrimination and calibration of the nomogram were evaluated by the area under the receiver operating characteristic curve (AUC) and Hosmer-Lemeshow test; performance was externally validated in Northeast China. Parameters in the model included gender, age, drinking status, marriage status, history of hypertension and hyperlipidemia, waist-to-hip ratio, FPG, and HbA1c. All variables were noninvasive, except FPG and HbA1c. The AUC of the nomogram for isolated high 2-hour plasma glucose was 0.759 (0.727-0.791) in the development dataset. The AUCs of the internal and externally validation datasets were 0.781 (0.712-0.833) and 0.803 (0.778-0.829), respectively. Application of the nomogram during the validation study showed good calibration, and the decision curve analysis indicated that the nomogram was clinically useful. This practical nomogram model may be a reliable screening tool to detect isolated high 2-hour plasma glucose for individualized assessment in patients with normal FPG and HbA1c. It should simplify clinical practice, and help clinicians in decision-making.

摘要

构建了一个工具,用于评估空腹血糖(FPG)和糖化血红蛋白(HbA1c)正常的患者是否需要口服葡萄糖耐量试验(OGTT)。数据来自于 2011 年 6 月至 11 月进行的纵向 REACTION 研究(14686 例,年龄≥40 岁)。在无糖尿病既往史的人群中,孤立性高 2 小时血糖定义为 2 小时血糖≥11.1mmol/L,FPG<7.0mmol/L,且 HbA1c<6.5%。采用逐步逻辑回归方法建立了高 2 小时血糖的预测列线图。通过接受者操作特征曲线下面积(AUC)和 Hosmer-Lemeshow 检验评估列线图的区分度和校准度;采用中国东北地区的外部验证来评估其性能。模型中的参数包括性别、年龄、饮酒状况、婚姻状况、高血压和高脂血症史、腰臀比、FPG 和 HbA1c。除 FPG 和 HbA1c 外,所有变量均为非侵入性的。在开发数据集,孤立性高 2 小时血糖列线图的 AUC 为 0.759(0.727-0.791)。内部验证数据集和外部验证数据集的 AUC 分别为 0.781(0.712-0.833)和 0.803(0.778-0.829)。验证研究中列线图的应用显示出良好的校准度,决策曲线分析表明该列线图具有临床应用价值。该实用的列线图模型可能是一种可靠的筛查工具,可用于检测 FPG 和 HbA1c 正常患者的孤立性高 2 小时血糖,以进行个体化评估。它将简化临床实践,帮助临床医生做出决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/38b554399ab8/fendo-13-943750-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/b069a8f4c943/fendo-13-943750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/2275b6141a7e/fendo-13-943750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/cd3bdfa612fc/fendo-13-943750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/f1cc8789e3e9/fendo-13-943750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/38b554399ab8/fendo-13-943750-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/b069a8f4c943/fendo-13-943750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/2275b6141a7e/fendo-13-943750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/cd3bdfa612fc/fendo-13-943750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/f1cc8789e3e9/fendo-13-943750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b2/9492843/38b554399ab8/fendo-13-943750-g005.jpg

相似文献

1
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose.孤立性高 2 小时血浆葡萄糖风险评估列线图的开发和验证。
Front Endocrinol (Lausanne). 2022 Sep 8;13:943750. doi: 10.3389/fendo.2022.943750. eCollection 2022.
2
Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making.用于预测从空腹血糖受损回归至正常血糖以辅助临床决策的列线图的验证
Fam Pract. 2016 Aug;33(4):401-7. doi: 10.1093/fampra/cmw031. Epub 2016 May 3.
3
Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.空腹血糖和糖化血红蛋白 A1c 联合用于糖尿病和糖调节受损的筛查。
Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17.
4
Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.联合使用空腹血糖浓度和糖化血红蛋白(HbA1c)或果糖胺可预测高危人群患糖尿病的可能性。
Diabetes Care. 1998 Aug;21(8):1221-5. doi: 10.2337/diacare.21.8.1221.
5
Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.空腹血糖和糖化血红蛋白不是亚洲印第安人社区新诊断糖尿病的最佳筛查方法。
Ethn Dis. 2018 Feb 1;28(1):19-24. doi: 10.18865/ed.28.1.19. eCollection 2018 Winter.
6
Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.冠心病患者糖尿病的省时筛查:来自欧洲动脉粥样硬化预防与逆转调查项目IV(EUROASPIRE IV)的报告
BMJ Open. 2016 Dec 8;6(12):e013835. doi: 10.1136/bmjopen-2016-013835.
7
Statistical Analysis on Threshold of Haemoglobin A1C (HBA1c) for Diabetes Diagnosis and the Relationship Between HBA1c and Plasma Glucose Concentrations in Chinese Diabetic High-Risk Groups.中国糖尿病高危人群糖化血红蛋白(HbA1c)用于糖尿病诊断的阈值统计分析及HbA1c与血浆葡萄糖浓度的关系
Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180711.
8
Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study.糖化血红蛋白单独或联合空腹血糖与口服葡萄糖耐量试验用于检测急性缺血性卒中患者糖代谢异常:一项中国横断面研究
BMC Neurol. 2014 Sep 12;14:177. doi: 10.1186/s12883-014-0177-0.
9
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.肾移植后糖尿病筛查中的空腹血糖和糖化血红蛋白
Transplantation. 2009 Aug 15;88(3):429-34. doi: 10.1097/TP.0b013e3181af1f53.
10
Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.评估 A1c 和 FPG 检测在筛查印度结核患者口服葡萄糖耐量试验诊断的新诊断糖尿病中的性能。
Diabetes Res Clin Pract. 2013 Oct;102(1):60-4. doi: 10.1016/j.diabres.2013.08.007. Epub 2013 Aug 31.

本文引用的文献

1
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.牛津皇家全科医生学院研究和监测中心初级保健网络中 SARS-CoV-2 患者的风险因素:一项横断面研究。
Lancet Infect Dis. 2020 Sep;20(9):1034-1042. doi: 10.1016/S1473-3099(20)30371-6. Epub 2020 May 15.
2
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.中国 2018 年美国糖尿病协会诊断标准下的中国大陆糖尿病患病率:全国横断面研究。
BMJ. 2020 Apr 28;369:m997. doi: 10.1136/bmj.m997.
3
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.
筛查伴冠状动脉疾病的糖代谢紊乱患者的血糖紊乱和危险因素管理:需要大幅改善的持续挑战:ESC EORP EUROASPIRE V 报告
Diabetes Care. 2020 Apr;43(4):726-733. doi: 10.2337/dc19-2165. Epub 2020 Feb 20.
4
A simple screening score to predict diabetes in cancer patients: A Korean nationwide population-based cohort study.一种预测癌症患者糖尿病的简易筛查评分:一项基于韩国全国人群的队列研究。
Medicine (Baltimore). 2019 Dec;98(51):e18354. doi: 10.1097/MD.0000000000018354.
5
Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.糖尿病相关全因和心血管死亡率在一个全国成年人队列中。
J Am Heart Assoc. 2019 Feb 19;8(4):e011295. doi: 10.1161/JAHA.118.011295.
6
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断:
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. doi: 10.2337/dc19-S002.
7
Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.2016 年和 2017 年美国成年人确诊 1 型和 2 型糖尿病的患病率:基于人群的研究。
BMJ. 2018 Sep 4;362:k1497. doi: 10.1136/bmj.k1497.
8
Novel nomogram for screening the risk of developing diabetes in a Korean population.用于筛查韩国人群发生糖尿病风险的新型列线图。
Diabetes Res Clin Pract. 2018 Aug;142:286-293. doi: 10.1016/j.diabres.2018.05.036. Epub 2018 Jun 7.
9
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
10
Missing data and multiple imputation in clinical epidemiological research.临床流行病学研究中的缺失数据与多重填补
Clin Epidemiol. 2017 Mar 15;9:157-166. doi: 10.2147/CLEP.S129785. eCollection 2017.